Effects of Low and High Doses of Atorvastatin on Arterial Compliance (original) (raw)

The Effect of Atorvastatin Intensity, Obesity, Gender, and

Mustafa Y . G . Younis

View PDFchevron_right

Atorvastatin treatment meets new European recommendations for the treatment of dyslipidemias

jana golob

Cardiologia Croatica, 2012

View PDFchevron_right

Atorvastatin Pleiotropism: Role in Cardioprotection

Gurfateh Singh

International Journal of Pharmaceutical & Biological …, 2011

View PDFchevron_right

Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk

Jesus Egido

European Journal of Pharmacology, 2008

View PDFchevron_right

To compare the efficacy of alternate day versus everyday dosing of atorvastatin in hyperlipidemic rabbits

Sarita Mulkalwar

International Journal of Basic and Clinical Pharmacology, 2016

View PDFchevron_right

Effects of atorvastatin on higher functions

GURUNATH Parale

European Journal of Clinical Pharmacology, 2006

View PDFchevron_right

Atherosclerosis

Adel Allam

Global Heart, 2014

View PDFchevron_right

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention

Vincenzo Pasceri

Journal of the American College of Cardiology, 2009

View PDFchevron_right

Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial

Mitch Dekoven

International Journal of General Medicine, 2013

View PDFchevron_right

Identify and Assess Drug Interactions with Atorvastatin in Inpatient Care

Kingsley E Adukpoh

2021

View PDFchevron_right

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial

Ali Raza

American Heart Journal, 2004

View PDFchevron_right

Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia

ALI RAZA

Journal of Atherosclerosis and Thrombosis, 2003

View PDFchevron_right

Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial

Bilal Zu'by

The American Journal of Cardiology, 2006

View PDFchevron_right

Statins: effects beyond cholesterol lowering

Garry Shen

Nephrology Dialysis Transplantation, 2001

View PDFchevron_right

Hypertension and Atrial Fibrillation

Simone Bianchi

Critical Pathways in Cardiology, 2014

View PDFchevron_right

An overview of pleiotropic effect of statins in cardiovascular disease

Kumud Upadhyaya

Pharmacy & pharmacology international journal, 2018

View PDFchevron_right

Atherosclerosis and Physical Activity

Ali Al-mamari

Oman Medical Journal, 2009

View PDFchevron_right

The THRombolysis and STatins (THRaST) study

Maurizio MelIs

Neurology, 2013

View PDFchevron_right

Effect of Pravastatin and Atorvastatin on Glucose Metabolism in NonDiabetic Patients with Hypercholesterolemia

Masao Moroi

Internal Medicine, 2006

View PDFchevron_right

Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients

Michael J Quon

International Journal of Cardiology, 2013

View PDFchevron_right

A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap study

Javier Martinez

Current Therapeutic Research, 2003

View PDFchevron_right

Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes

Marco Lombardo

Atherosclerosis, 2010

View PDFchevron_right

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

Steen Jensen

European Heart Journal, 2008

View PDFchevron_right

Atorvastatin improves cardiac function and remodeling in chronic non-ischemic heart failure: A clinical and pre-clinical study

Adel Omar

The Egyptian Heart Journal, 2015

View PDFchevron_right

Faculty of 1000 evaluation for Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

Søren Sheikh

F1000 - Post-publication peer review of the biomedical literature, 2006

View PDFchevron_right

Arterial compliance in obese young subjects

Guido Grassi

Journal of Hypertension, 1993

View PDFchevron_right

Comparison of Atorvastatin and Simvastatin in Prevention of Atrial Fibrillation After Successful Cardioversion

Qiang Yao

International Heart Journal, 2009

View PDFchevron_right

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

Sandra Stinnett

Circulation, 1992

View PDFchevron_right

Rosuvastatin in Older Patients with Systolic Heart Failure

John Kjekshus

New England Journal of Medicine, 2007

View PDFchevron_right

Cardiac Titin and Heart Disease

Henk Granzier

Journal of Cardiovascular Pharmacology, 2014

View PDFchevron_right

Metabolic syndrome and pulse pressure

G. Pepe

Diabetes, Obesity and Metabolism, 2007

View PDFchevron_right

Vascular Complications in Human Disease

Michael Dashwood

2008

View PDFchevron_right

Therapeutical Approach of Arterial Hypertension

Genel Sur

Pharmaceutica Analytica Acta, 2011

View PDFchevron_right

Capítulo 4 - Estratificaçã o de Risco Cardiovascular

Vera Koch

Arquivos Brasileiros de Cardiologia, 2016

View PDFchevron_right

Comparative evaluation of the effect of statin drugs in Hyperlipidaemic patients

JAWAHAR FAROOK

2011

View PDFchevron_right